Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/127563
Registo completo
Campo DCValorIdioma
dc.creatorFigueiredo, J-
dc.creatorMelo, S-
dc.creatorGamet, K-
dc.creatorGodwin, T-
dc.creatorSeixas, S-
dc.creatorSanches, J-
dc.creatorGuilford, P-
dc.creatorSeruca, R-
dc.date.accessioned2020-06-18T11:12:27Z-
dc.date.available2020-06-18T11:12:27Z-
dc.date.issued2018-
dc.identifier.issn1476-4598-
dc.identifier.urihttps://hdl.handle.net/10216/127563-
dc.description.abstractThe aim of this study was to uncover the pathogenic relevance and the underlying molecular mechanism of a novel CDH1 variant found in a Hereditary Diffuse Gastric Cancer family (p.L13_L15del), which affects the signal peptide of E-cadherin without changing the remaining predicted sequence. We verified that p.L13_L15del cells yield low levels of E-cadherin, decreased cell adhesion and enhanced cell invasion. Further, we demonstrated that the disruption of the highly conserved hydrophobic core of the signal peptide hampers the binding of cellular components crucial for E-cadherin translation and translocation into the endoplasmic reticulum, constituting a new molecular basis for the loss of a tumour suppressor gene causative of hereditary cancer.-
dc.description.sponsorshipThis work was financed by FEDER funds through the Operational Programme for Competitiveness Factors (COMPETE), Programa Operacional Regional do Norte (Norte 2020) and by National Funds through the Portuguese Foundation for Science and Technology (FCT), under the projects PTDC/BIM-ONC/0171/2012, PTDC/BIM-ONC/0281/2014, PTDC/BBB-IMG/0283/2014, NORTE-01-0145-FEDER-000029; Post-Doctoral grant SFRH/BPD/87705/2012-JF and Doctoral grant SFRH/BD/108009/2015-SM. We acknowledge the American Association of Patients with Hereditary Gastric Cancer “No Stomach for Cancer” for funding Seruca and Figueiredo research.-
dc.language.isoeng-
dc.publisherBMC-
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBPD%2F87705%2F2012/PT-
dc.relation.ispartofMolecular Cancer, vol.17(1):112-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.meshAdult-
dc.subject.meshAntigens, CD / genetics-
dc.subject.meshAntigens, CD / metabolism-
dc.subject.meshCadherins / genetics-
dc.subject.meshCadherins / metabolism-
dc.subject.meshCell Adhesion-
dc.subject.meshEndoplasmic Reticulum / metabolism-
dc.subject.meshFemale-
dc.subject.meshGenetic Variation-
dc.subject.meshHumans-
dc.subject.meshMale-
dc.subject.meshProtein Sorting Signals-
dc.subject.meshProtein Transport-
dc.subject.meshSequence Analysis, DNA-
dc.subject.meshStomach Neoplasms / genetics-
dc.subject.meshStomach Neoplasms / metabolism-
dc.titleE-cadherin signal sequence disruption: A novel mechanism underlying hereditary cancer-
dc.typeArtigo em Revista Científica Internacional-
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde-
dc.identifier.doi10.1186/s12943-018-0859-0-
dc.relation.publisherversionhttps://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-018-0859-0-
Aparece nas coleções:I3S - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
10.1186-s12943-018-0859-0.pdf4.32 MBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons